BioHarvest Sciences (XCNQ:BHSC) LT-Debt-to-Total-Asset : 0.06 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is BioHarvest Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. BioHarvest Sciences's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.06.

BioHarvest Sciences's long-term debt to total assets ratio declined from Dec. 2022 (0.18) to Mar. 2024 (0.06). It may suggest that BioHarvest Sciences is progressively becoming less dependent on debt to grow their business.

BioHarvest Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for BioHarvest Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences LT-Debt-to-Total-Asset Chart

BioHarvest Sciences Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.45

0.22

0.18

0.10

BioHarvest Sciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.18	0.18	0.14	0.10	0.06

BioHarvest Sciences LT-Debt-to-Total-Asset Calculation

BioHarvest Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1.912	/	20.127
	=	0.09

BioHarvest Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	0.983	/	17.479
	=	0.06

BioHarvest Sciences (XCNQ:BHSC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

BioHarvest Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences (XCNQ:BHSC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (XCNQ:BHSC) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

CNVCF:USA 8MV:Germany

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

BioHarvest Sciences (XCNQ:BHSC) Headlines

No Headlines